药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arformoterol
Linagliptin
The metabolism of Linagliptin can be decreased when combined with Rilpivirine.
Arformoterol
Fosaprepitant
The metabolism of Fosaprepitant can be decreased when combined with Rilpivirine.
Arformoterol
Rufinamide
The metabolism of Rufinamide can be decreased when combined with Rilpivirine.
Arformoterol
Metreleptin
The metabolism of Rilpivirine can be increased when combined with Metreleptin.
Arformoterol
Belantamab mafodotin
The excretion of Belantamab mafodotin can be decreased when combined with Rilpivirine.
Arformoterol
Remdesivir
The excretion of Remdesivir can be decreased when combined with Rilpivirine.
Arformoterol
Grazoprevir
The excretion of Grazoprevir can be decreased when combined with Rilpivirine.
Arformoterol
Selexipag
The excretion of Selexipag can be decreased when combined with Rilpivirine.
Arformoterol
Paritaprevir
The excretion of Paritaprevir can be decreased when combined with Rilpivirine.
Arformoterol
Levosalbutamol
The excretion of Levosalbutamol can be decreased when combined with Rilpivirine.
Arformoterol
Technetium Tc-99m mebrofenin
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Rilpivirine.
Arformoterol
Gadoxetic acid
The excretion of Gadoxetic acid can be decreased when combined with Rilpivirine.
Arformoterol
Atrasentan
The excretion of Atrasentan can be decreased when combined with Rilpivirine.
Arformoterol
Relugolix
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Relugolix.
Arformoterol
Triclabendazole
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Triclabendazole.
Arformoterol
Ebastine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Ebastine.
Arformoterol
Efonidipine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Efonidipine.
Arformoterol
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Rilpivirine.
Arformoterol
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Rilpivirine.
Arformoterol
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Acetyldigoxin.